Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030193 (
pain
)
261,466
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neuropathic pain, caused by various central and peripheral nerve disorders, is especially problematic because of its severity, chronicity, and resistance to simple analgesics. Pathophysiologic changes responsible for generating
pain
following nerve lesions are usually independent of the etiology of the primary neuronal damage. Several fundamental mechanisms could be identified as principle conditions in the development of neuropathic
pain
; they include peripheral and central sensitization,
disinhibition
, sympathetically maintained
pain
, and cortical reorganization. Classifying neuropathic
pain
by these basic mechanisms is considered appropriate for basing new treatment approaches. In coming years, several advances are expected in the basic and clinical sciences of neuropathic
pain
which will provide new and improved therapies for patients continuing to experience this sometimes very disabling condition.
...
PMID:[Symptoms and pathophysiological mechanisms of neuropathic pain syndromes]. 1913 74
Inhibition in the spinal cord dorsal horn is crucial for maintaining separation of touch and
pain
modalities. Disruption of this inhibition results in allodynia, allowing low-threshold drive onto
pain
and temperature-sensitive projection neurons. This low-threshold (LT) excitatory pathway is normally under strong inhibition. We hypothesized that superficial dorsal horn inhibitory neurons, which would be ideally located to suppress LT drive onto projection neurons in a feedforward manner, are driven by LT input. In addition, because
disinhibition
-induced allodynia shares some features with the immature dorsal horn such as elevated sensitivity to LT input, we also questioned whether LT drive onto inhibitory neurons changes during postnatal maturation. To investigate these questions, slices were made at different ages from transgenic mice with enhanced green fluorescent protein expression in GABAergic neurons and whole-cell recordings were made from these fluorescent neurons. Evoked synaptic activity was measured in response to electrical stimulation of the dorsal root. We demonstrate that Abeta fibers activate a significant proportion of superficial dorsal horn GABAergic neurons. This occurs with similar excitatory synaptic drive throughout postnatal maturation, but with a greater prevalence at younger ages. These GABAergic neurons are well situated to contribute to suppressing LT activation of output projection neurons. In addition, the majority of these GABAergic neurons also had convergent input from high-threshold fibers, suggesting that this novel subclass of GABAergic neurons is important for gating innocuous as well as noxious information.
...
PMID:Low-threshold primary afferent drive onto GABAergic interneurons in the superficial dorsal horn of the mouse. 1915 95
For transcranial magnetic stimulation (TMS), the coupling of induced electric fields with neurons in gray matter is not well understood. There is little information on optimal stimulation parameters and on basic cellular mechanisms. For this reason, magnetic stimulation of spontaneously active neuronal networks, grown on microelectrode arrays in culture, was employed as a test environment. This allowed use of smaller coils and the continual monitoring of network action potential (AP) activity before, during, and for long periods after stimulation. Biphasic, rectangular, and 500 micros long pulses were used at mean pulse frequencies (MPFs) ranging from 3 to 100 Hz on both spinal cord (SC) and frontal cortex (FC) cultures. Contrary to stimulation of organized fiber bundles, APs were not elicited directly. Responses were predominantly inhibitory, dose dependent, with onset times between 10 s and several minutes. Spinal networks showed a greater sensitivity to activity suppression. Under pharmacological
disinhibition
, some excitation was seen at low pulse frequencies. FC cultures showed greater excitatory responses than SC networks. The observed primary inhibitory responses imply interference with synaptic exocytosis mechanisms. With 20,000 pulses at 10 Hz, 40% inhibition was maintained for over 30 min with full recovery, suggesting possible application to nonchemical, noninvasive
pain
management.
...
PMID:Magnetic stimulation and depression of mammalian networks in primary neuronal cell cultures. 1920 81
Intense stress and fear have long been known to give rise to a suppression of
pain
termed "stress-induced analgesia", mediated by brainstem
pain
-modulating circuitry, including
pain
-inhibiting neurons of the rostral ventromedial medulla. However, stress does not invariably suppress
pain
, and indeed, may exacerbate it. Although there is a growing support for the idea of "stress-induced hyperalgesia", the neurobiological basis for this effect remains almost entirely unknown. Using simultaneous single-cell recording and functional analysis, we show here that stimulation of the dorsomedial nucleus of the hypothalamus, known to be a critical component of central mechanisms mediating neuroendocrine, cardiovascular and thermogenic responses to mild or "emotional" stressors such as air puff, also triggers thermal hyperalgesia by recruiting
pain
-facilitating neurons, "ON-cells", in the rostral ventromedial medulla. Activity of identified RVM ON-cells, OFF-cells and NEUTRAL cells, nociceptive withdrawal thresholds, rectal temperature, and heart rate were recorded in lightly anesthetized rats. In addition to the expected increases in body temperature and heart rate,
disinhibition
of the DMH induced a robust activation of ON-cells, suppression of OFF-cell firing and behavioral hyperalgesia. Blocking ON-cell activation prevented hyperalgesia, but did not interfere with DMH-induced thermogenesis or tachycardia, pointing to differentiation of neural substrates for autonomic and nociceptive modulation within the RVM. These data demonstrate a top-down activation of brainstem
pain
-facilitating neurons, and suggest a possible neural circuit for stress-induced hyperalgesia.
Pain
2009 Apr
PMID:A possible neural basis for stress-induced hyperalgesia. 1923 70
Dynamic mechanical allodynia is a widespread and intractable symptom of neuropathic
pain
for which there is a lack of effective therapy. We recently provided a novel perspective on the mechanisms of this symptom by showing that a simple switch in trigeminal glycine synaptic inhibition can turn touch into
pain
by unmasking innocuous input to superficial dorsal horn nociceptive specific neurons through a local excitatory, NMDA-dependent neural circuit involving neurons expressing the gamma isoform of protein kinase C. Here, we further investigated the clinical relevance and processing of glycine
disinhibition
. First, we showed that glycine
disinhibition
with strychnine selectively induced dynamic but not static mechanical allodynia. The induced allodynia was resistant to morphine. Second, morphine did not prevent the activation of the neural circuit underlying allodynia as shown by study of Fos expression and extracellular-signal regulated kinase phosphorylation in dorsal horn neurons. Third, in contrast to intradermal capsaicin injections, light, dynamic mechanical stimuli applied under
disinhibition
did not produce neurokinin 1 (NK1) receptor internalization in dorsal horn neurons. Finally, light, dynamic mechanical stimuli applied under
disinhibition
induced Fos expression only in neurons that did not express NK1 receptor. To summarize, the selectivity and morphine resistance of the glycine-
disinhibition
paradigm adequately reflect the clinical characteristics of dynamic mechanical allodynia. The present findings thus reveal the involvement of a selective dorsal horn circuit in dynamic mechanical allodynia, which operates through superficial lamina nociceptive-specific neurons that do not bear NK1 receptor and provide an explanation for the differences in the pharmacological sensitivity of neuropathic
pain
symptoms.
...
PMID:Glycine inhibitory dysfunction induces a selectively dynamic, morphine-resistant, and neurokinin 1 receptor- independent mechanical allodynia. 1924 26
Cluster headache (CH) is a neurovascular headache disease characterized by recurrent, strictly unilateral, severe
pain
attacks. Despite its typical clinical features, including circadian rhythm of the attacks and ipsilateral autonomic dysfunction, the underlying pathophysiology of CH is still unclear. Electrophysiological data point to central
disinhibition
of the trigeminal nociceptive system as one of the key mechanisms of CH
pain
. Therefore, altered habituation pattern and changes within trigeminal-facial neuronal circuits due to central sensitization seem to be involved. One biochemical correlate is probably represented in dysfunctions of serotonergic raphe nuclei-hypothalamic pathways. Structural and functional imaging data show an alteration of hypothalamic structures in CH patients, supporting the hypothesis that the hypothalamus, according to its function as a circadian pacemaker, plays a pivotal role in CH pathology. Cortical and brainstem reflexes are reviewed to illuminate the pathophysiology of CH.
Curr
Pain
Headache Rep 2009 Apr
PMID:The electrophysiology of cluster headache. 1927 82
Primary dysmenorrhea (PDM, menstrual
pain
without pelvic abnormality) is the most common gynecological disorder for women in the reproductive age. It is characterized by cramping
pain
and enhanced
pain
sensitivity during the menstruation period. PDM has been associated with peripheral and central sensitization. Abnormal brain mechanisms may further contribute to development and maintenance of the state. Using fluoro-deoxyglucose positron emission tomography, increased activity was observed in prefrontal/orbitofrontal regions and left ventral posterior thalamus while decreased activity mainly was observed in sensorimotor regions of the left hemisphere at onset compared to offset of PDM. These results were specific to menstrual
pain
and were not found in menstrual matched controls. Orbitofrontal activities were positively related to while somatosensory activities where negatively related to subjective
pain
ratings. These results show that ongoing menstrual
pain
in PDM is accompanied by abnormal brain metabolism.
Disinhibition
of thalamo-orbitofrontal-prefrontal networks may contribute to the generation of
pain
and hyperalgesia in PDM possibly by maintaining spinal and thalamic sensitization while increasing negative affect. Excessive excitatory input during menstrual
pain
may induce compensatory inhibitory mechanism in several somatic sensorimotor regions.
...
PMID:Abnormal cerebral metabolism during menstrual pain in primary dysmenorrhea. 1936 53
Neuropathic pain is triggered by lesions to the somatosensory nervous system that alter its structure and function so that
pain
occurs spontaneously and responses to noxious and innocuous stimuli are pathologically amplified. The
pain
is an expression of maladaptive plasticity within the nociceptive system, a series of changes that constitute a neural disease state. Multiple alterations distributed widely across the nervous system contribute to complex
pain
phenotypes. These alterations include ectopic generation of action potentials, facilitation and
disinhibition
of synaptic transmission, loss of synaptic connectivity and formation of new synaptic circuits, and neuroimmune interactions. Although neural lesions are necessary, they are not sufficient to generate neuropathic
pain
; genetic polymorphisms, gender, and age all influence the risk of developing persistent
pain
. Treatment needs to move from merely suppressing symptoms to a disease-modifying strategy aimed at both preventing maladaptive plasticity and reducing intrinsic risk.
...
PMID:Neuropathic pain: a maladaptive response of the nervous system to damage. 1940 Jul 24
Local inhibitory interneurons in the dorsal horn play an important role in the control of excitability at the segmental level and thus determine how nociceptive information is relayed to higher structures. Regulation of inhibitory interneuron activity may therefore have critical consequences on
pain
perception. Indeed,
disinhibition
of dorsal horn neuronal networks disrupts the balance between excitation and inhibition and is believed to be a key mechanism underlying different forms of
pain
hypersensitivity and chronic pain states. In this context, studying the source and the synaptic properties of the inhibitory inputs that the inhibitory interneurons receive is important in order to predict the impact of drug action at the network level. To address this, we studied inhibitory synaptic transmission in lamina II inhibitory interneurons identified under visual guidance in spinal slices taken from transgenic mice expressing enhanced green fluorescent protein (EGFP) under the control of the GAD promoter. The majority of these cells fired tonically to a long depolarizing current pulse. Monosynaptically evoked inhibitory postsynaptic currents (eIPSCs) in these cells were mediated by both GABAA and glycine receptors. Consistent with this, both GABAA and glycine receptor-mediated miniature IPSCs were recorded in all of the cells. These inhibitory inputs originated at least in part from local lamina II interneurons as verified by simultaneous recordings from pairs of EGFP+ cells. These synapses appeared to have low release probability and displayed potentiation and asynchronous release upon repeated activation. In summary, we report on a previously unexamined component of the dorsal horn circuitry that likely constitutes an essential element of the fine tuning of nociception.
Mol
Pain
2009 May 12
PMID:Inhibitory coupling between inhibitory interneurons in the spinal cord dorsal horn. 1943 97
Many chronic pain syndromes are associated with hypersensitivity to painful stimuli and with reduced endogenous
pain
inhibition. These findings suggest that modulation of
pain
-related information may be linked to the onset or maintenance of chronic pain. The combination of heightened
pain
sensitivity and reduced
pain
inhibition seems to predispose individuals to greater risk for increased acute clinical
pain
. It is unknown whether such
pain
processing abnormalities may also place individuals at increased risk for chronic pain. Psychophysical methods can be used for the evaluation of
pain
sensitivity and
pain
inhibition. Long-term prospective studies that could yield insight into the role of heightened
pain
sensitivity and
pain
disinhibition
for the development of chronic pain disorders like fibromyalgia in the general population are lacking, however.
...
PMID:Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. 1964 41
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>